Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 72 (2022): Issue 4 (December 2022)
Open Access
Direct oral anticoagulants (DOACs): From the laboratory point of view
Sandra Margetić
Sandra Margetić
,
Sandra Šupraha Goreta
Sandra Šupraha Goreta
,
Ivana Ćelap
Ivana Ćelap
and
Marija Razum
Marija Razum
| Oct 18, 2022
Acta Pharmaceutica
Volume 72 (2022): Issue 4 (December 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Oct 18, 2022
Page range:
459 - 482
Accepted:
Aug 09, 2022
DOI:
https://doi.org/10.2478/acph-2022-0034
Keywords
direct oral anticoagulants ( DOACs)
,
anticoagulation
,
laboratory monitoring
© 2022 Sandra Margetić et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.